Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease‐Activated Receptor Pathway-Reference-Cited by-同舟云学术

Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease‐Activated Receptor Pathway

Published:2019-04-16 Issue:8 Volume:8 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Ichikawa Hiroaki¹,Shimada Michiko¹,Narita Masato¹,Narita Ikuyo¹,Kimura Yoshihiro¹,Tanaka Makoto²,Osanai Tomohiro³,Okumura Ken⁴,Tomita Hirofumi¹²

Affiliation:

1. Department of Cardiology and Nephrology Hirosaki University Graduate School of Medicine Hirosaki Japan

2. Department of Stroke and Cerebrovascular Medicine Hirosaki University Graduate School of Medicine Hirosaki Japan

3. Department of Nursing Science Hirosaki University Graduate School of Health Sciences Hirosaki Japan

4. Division of Cardiology Saiseikai Kumamoto Hospital Kumamoto Japan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. The renin-angiotensin-aldosterone system and fibrinolysis

2. Prothrombotic effects of angiotensin;Brown NJ;Adv Intern Med,2000

3. Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage

4. Relationship of Fibrinogen Levels and Hemostatic Abnormalities With Organ Damage in Hypertension

5. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulation in Chronic Kidney Disease;Drugs;2024-08-09

2. Comparative Cardioprotective Effectiveness: NOACs vs. Nattokinase—Bridging Basic Research to Clinical Findings;Biomolecules;2024-08-07

3. Evaluating Renal Benefits of Rivaroxaban Versus Vitamin K Antagonists in Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-world Evidence;European Cardiology Review;2024-06-13

4. Inhibitory effect of rivaroxaban on protease-activated receptor-2 in circulating neutrophils among patients with atrial fibrillation;IJC Heart & Vasculature;2024-06

5. Proteomic analysis of extracellular vesicle cargoes mirror the cardioprotective effects of rivaroxaban in patients with venous thromboembolism;PROTEOMICS – Clinical Applications;2024-01-09